Efficacy and Safety of Apremilast in Oncological Patients with Moderate-to-Severe Plaque Psoriasis: A 5 years Retrospective Observational Study
Caterina Lanna,1 Antonia Rivieccio,1 Martina Vultaggio,1 Ruslana Gaeta Shumak,1 Francesco Maria Bonacci,1 Fabio Artosi,1 Cristiana Borselli,1 Gaetana Costanza,2 Luca Bianchi,1 Elena Campione1 1Dermatology Unit, Department of Systems Medicine, Università di Roma Tor Vergata, Roma, Italia; 2Virology U...
Saved in:
| Main Authors: | Lanna C, Rivieccio A, Vultaggio M, Gaeta Shumak R, Bonacci FM, Artosi F, Borselli C, Costanza G, Bianchi L, Campione E |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-05-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-and-safety-of-apremilast-in-oncological-patients-with-moderat-peer-reviewed-fulltext-article-CCID |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assessing the Effect of Apremilast on Serum Leptin levels in Obese Patients with Psoriasis
by: Haitham Mohammed Saad, et al.
Published: (2024-12-01) -
A Comparative Study on Efficacy and Safety of Methotrexate Versus Apremilast in the Management of Chronic Plaque Psoriasis: Tertiary Care Center Based Interventional Study
by: Alisha Aryal, et al.
Published: (2024-10-01) -
A Comparative Study on Efficacy and Safety of Methotrexate Versus Apremilast in the Management of Chronic Plaque Psoriasis: Tertiary Care Center Based Interventional Study
by: Alisha Aryal, et al.
Published: (2024-10-01) -
Successful treatment by deucravacitinib of psoriasis refractory to apremilast
by: Shigeki Inui, et al.
Published: (2025-06-01) -
High Systemic Disease Risk and Therapeutic Delays in Plaque Psoriasis: A Retrospective Analysis of Apremilast Use in the British Association of Dermatologists Biologic and Immunomodulators Register (BADBIR)
by: Kave Shams, et al.
Published: (2025-03-01)